GR1007629B - Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης - Google Patents
Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινηςInfo
- Publication number
- GR1007629B GR1007629B GR20110100407A GR20110100407A GR1007629B GR 1007629 B GR1007629 B GR 1007629B GR 20110100407 A GR20110100407 A GR 20110100407A GR 20110100407 A GR20110100407 A GR 20110100407A GR 1007629 B GR1007629 B GR 1007629B
- Authority
- GR
- Greece
- Prior art keywords
- release pharmaceutical
- controlled
- pharmaceutical formulation
- dopamine agonist
- ergoline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά μια στερεά φαρμακευτική σύνθεση ελεγχόμενης αποδέσμευσης για από του στόματος χορήγηση που περιέχει μια θεραπευτικώς αποτελεσματική ποσότητα ενός μη εργολινικού αγωνιστή της ντοπαμίνης ή ένα φαρμακευτικά αποδεκτό άλας, παράγωγο ή πολύμορφο αυτής, η οποία σύνθεση χαρακτηρίζεται από το ότι περιέχει μια αποτελεσματική ποσότητα τουλάχιστον ενός εκδόχου που επιλέγεται από έναν μη διογκούμενο παράγοντα, έναν παράγοντα που δημιουργεί γέλη, και μια αμφιφιλική ουσία. Επίσης παρέχεται μέθοδος για την παρασκευή της εν λόγω σύνθεσης.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100407A GR1007629B (el) | 2011-07-13 | 2011-07-13 | Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης |
PCT/EP2012/002831 WO2013007360A1 (en) | 2011-07-13 | 2012-07-05 | Controlled release pharmaceutical composition of non-ergoline dopamine agonist |
EP12751249.9A EP2731592A1 (en) | 2011-07-13 | 2012-07-05 | Controlled release pharmaceutical composition of non-ergoline dopamine agonist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100407A GR1007629B (el) | 2011-07-13 | 2011-07-13 | Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1007629B true GR1007629B (el) | 2012-06-29 |
Family
ID=45930912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20110100407A GR1007629B (el) | 2011-07-13 | 2011-07-13 | Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2731592A1 (el) |
GR (1) | GR1007629B (el) |
WO (1) | WO2013007360A1 (el) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070059365A1 (en) * | 2003-08-22 | 2007-03-15 | Pollock Peta E | Novel formulation of ropinirole |
WO2009023761A2 (en) * | 2007-08-14 | 2009-02-19 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions comprising ropinirole |
WO2010012482A1 (en) * | 2008-08-01 | 2010-02-04 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Ropinirole composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
-
2011
- 2011-07-13 GR GR20110100407A patent/GR1007629B/el not_active IP Right Cessation
-
2012
- 2012-07-05 EP EP12751249.9A patent/EP2731592A1/en not_active Withdrawn
- 2012-07-05 WO PCT/EP2012/002831 patent/WO2013007360A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070059365A1 (en) * | 2003-08-22 | 2007-03-15 | Pollock Peta E | Novel formulation of ropinirole |
WO2009023761A2 (en) * | 2007-08-14 | 2009-02-19 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions comprising ropinirole |
WO2010012482A1 (en) * | 2008-08-01 | 2010-02-04 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Ropinirole composition |
Non-Patent Citations (2)
Title |
---|
R. B. NILESH ET AL: "Formulation and Evaluation of Transdermal patches of Ropinirole HCl", RESEARCH JOURNAL OF PHARMACEUTICAL, BIOLOGICAL AND CHEMICAL SCIENCES, vol. 2, no. 1, 1 March 2011 (2011-03-01), pages 138 - 148, XP055025644 * |
SRAVANTHI ANAMPALLY ET AL: "Development of ropinirole (free base) transdermal patch using blends of hydroxypropyl methylcellulose/ Eudragits and its in vitro/ in vivo characterization", ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, vol. 3, no. 4, 1 July 2011 (2011-07-01), pages 89 - 98, XP055025634 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013007360A1 (en) | 2013-01-17 |
EP2731592A1 (en) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020000268A (es) | Agonista de fxr. | |
WO2012035559A3 (en) | Sustained release pharmaceutical compositions comprising pregabalin | |
MY160728A (en) | Morpholinothiazoles as alpha 7 positive allosteric modulators | |
IN2015DN01673A (el) | ||
BR112012021681A2 (pt) | rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração. | |
EA201190161A1 (ru) | Способ получения твердых лекарственных форм солифенацина и его фармацевтически приемлемых солей для перорального введения | |
MX2010000856A (es) | Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. | |
MX2013012588A (es) | Inhibidores de cinasa. | |
WO2013188273A8 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
WO2009140341A3 (en) | Atorvastatin compositions | |
JP2015510916A5 (el) | ||
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
TN2013000533A1 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
EP3615011A4 (en) | PHARMACEUTICAL COMPOSITION FOR IN VIVO ADMINISTRATION, PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE PRINCIPLE SENSITIVELY INSOLUBLE IN WATER | |
MX2013001637A (es) | Composiciones farmaceuticas de liberacion controlada oral de blonanserina. | |
WO2010137040A3 (en) | Novel pharmaceutical compositions of ranolazine | |
UA105285C2 (uk) | Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
MX370184B (es) | Composición farmacéutica que comprende fingolimod. | |
GR1008821B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου | |
GR1007629B (el) | Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης | |
GR1008819B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου | |
GR1008169B (el) | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου | |
WO2013054178A3 (en) | Extended release pharmaceutical compositions containing carmabazepine | |
GR1007712B (el) | Φαρμακευτικο σκευασμα περιεχον εναν ανταγωνιστη των υποδοχεων των λευκοτριενων και μεθοδος για την παρασκευη αυτου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20120713 |
|
ML | Lapse due to non-payment of fees |
Effective date: 20170207 |